Showing results (131-140 of 165) with videos related to
Sort By:
Pageof 17
Kidney International. Supplement|December 1, 1995
Isoprenoids and Ras: potential role in chronic rejectionM P O'Donnell, B L Kasiske, Z A Massy, et al.Kidney International|March 21, 1998
Renal cell cytokine production stimulates HIV-1 expression in chronically HIV-1-infected monocytesM P O'Donnell, C C Chao, G Gekker, et al.Kidney International. Supplement|January 4, 1998
Irbesartan lowers blood pressure and ameliorates renal injury in experimental non-insulin-dependent diabetes mellitusM P O'Donnell, G S Crary, H Oda, et al.Immunology|April 1, 1985
Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathwayH A Verbrugh, D A Lee, G R Elliott, et al.British Journal of Clinical Pharmacology|September 1, 1987
The effect of famotidine on renal function in patients with renal insufficiencyP A Abraham, J A Opsahl, C E Halstenson, et al.The Journal of Infectious Diseases|June 1, 1983
Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysisH A Verbrugh, W F Keane, J R Hoidal, et al.Therapeutic Drug Monitoring|September 1, 1987
Influence of gender on the disposition of cefotaxime and desacetylcefotaximeD R Guay, G R Matzke, K L Heim, et al.Journal of the American Society of Nephrology : JASN|October 1, 1995
The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker ratsG S Crary, S K Swan, M P O'Donnell, et al.Antimicrobial Agents and Chemotherapy|November 1, 1989
Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosingD R Guay, W M Awni, C E Halstenson, et al.Journal of Clinical Pharmacology|October 1, 1987
Disposition of famotidine in renal insufficiencyC E Halstenson, P A Abraham, J A Opsahl, et al.Pageof 17